Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 9,301.2%.

ASSET	% RETURN
Regencell Bioscience (RGC)	9,301.2%
CannBioRx Life Sciences (ATNFW)	4,287.76%
DeFi Development (DFDV)	2,368.42%
WW International, Inc Common Stock (WW)	2,267.18%
HCM II Acquisition (HONDW)	2,055.17%
Protagenic Therapeutics (PTIXW)	2,038.46%
Blue Gold Limited Warrant (BGLWW)	1,813.5%
Oncology Institute (TOIIW)	1,448.81%
Zepp Health (ZEPP)	1,438.46%
Newegg Commerce (NEGG)	1,347.25%
Diginex Limited Ordinary Shares (DGNX)	1,237.32%
CEA Industries (BNCWW)	1,108.72%
CEA Industries (VAPEW)	1,108.05%
Oncology Institute (TOI)	1,105.88%
K Wave Media (KWMWW)	1,065.05%
USA Rare Earth (USARW)	948%
Abivax SA American Depositary Shares (ABVX)	928.04%
Cohen Circle Acquisition Corp I Warrant (CCIRW)	905.35%
Webull Corporation Warrants (BULLW)	886.44%
Anbio Biotechnology Class A Ordinary Shares (NNNN)	838.97%
Rich Sparkle Holdings Limited Ordinary Shares (ANPA)	830.97%
Ainos (AIMDW)	812.98%
Above Food Ingredients Inc Warrants (ABVEW)	809.09%
Global Interactive Technologies (GITS)	792.12%
BT Brands Inc Warrant (BTBDW)	763.79%